KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Other financing activities (2016 - 2026)

Tenet Healthcare (THC) has disclosed Other financing activities for 17 consecutive years, with -$77.0 million as the latest value for Q1 2026.

  • For Q1 2026, Other financing activities fell 1000.0% year-over-year to -$77.0 million; the TTM value through Mar 2026 reached -$38.0 million, down 144.19%, while the annual FY2025 figure was $32.0 million, 44.83% down from the prior year.
  • Other financing activities hit -$77.0 million in Q1 2026 for Tenet Healthcare, down from $16.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $126.0 million in Q2 2022 and bottomed at -$102.0 million in Q1 2022.
  • Average Other financing activities over 5 years is $2.9 million, with a median of $1.0 million recorded in 2023.
  • Year-over-year, Other financing activities skyrocketed 3300.0% in 2024 and then tumbled 2300.0% in 2025.
  • Tenet Healthcare's Other financing activities stood at $3.0 million in 2022, then surged by 2133.33% to $67.0 million in 2023, then fell by 8.96% to $61.0 million in 2024, then plummeted by 73.77% to $16.0 million in 2025, then tumbled by 581.25% to -$77.0 million in 2026.
  • According to Business Quant data, Other financing activities over the past three periods came in at -$77.0 million, $16.0 million, and $71.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.